Renvela

Active Ingredient(s): Sevelamer Carbonate
FDA Approved: * October 19, 2007
Pharm Company: * GENZYME
Category: Hyperphosphatemia

Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate). Contents 1 Chemistry and pharmacology 2 Medical uses 3 Contraindications 4 Adverse effects 5 Other eff... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Renvela RENVELA;800
Renvela 800 mg Oral Tablet
NDC: 58468-0130
Labeler:
Genzyme Corporation
Renvela RENVELA;800
Renvela 800 mg Oral Tablet
NDC: 0179-0043
Labeler:
Kaiser Foundation Hospitals
Renvela RENVELA;800
Renvela 800 mg Oral Tablet, Film Coated
NDC: 17856-0130
Labeler:
Atlantic Biologicals Corps
Renvela RENVELA;800
Renvela 800 mg Oral Tablet
NDC: 55154-9728
Labeler:
Cardinal Health
Renvela RENVELA;800
Renvela 800 mg Oral Tablet, Film Coated
NDC: 68151-5113
Labeler:
Carilion Materials Management
Renvela RENVELA;800
Renvela 800 mg Oral Tablet, Film Coated
NDC: 69189-0133
Labeler:
Avera Mckennan Hospital
Renvela 2400 mg/1 Oral Powder, for Suspension
NDC: 58468-0131
Labeler:
Genzyme Corporation
Renvela 800 mg/1 Oral Powder, for Suspension
NDC: 58468-0132
Labeler:
Genzyme Corporation

Related Brands

Drugs with the same active ingredients

Popular Topics

Renvela experiences

Any problems from taking renvela or it's generic sevelamer carbonate 800 mg? If so, please let me know. ## Hello, Ro...

1 REPLY
Renvela

Do you take renvela before, during or after eating?...